Promotion
Promotion - most related articles:
-
Job promotion bad for mental health - 4.6
-
Kroger to invest $3 million for breast cancer awareness - 2.7
-
Strong health system in Canada by 2020, says CNA - 2.4
-
Homeopathy medicines and H1N1 - a rational approach needed - 2.3
-
BioIQ discounted cholesterol test kits for women to detect heart disease risk - 2.2
-
Guidelines for information on unapproved uses of medical products - 2.1
Promotion articles
Diabetes early signs in kids as young as 7Research conducted under the direction of Melinda Sothern, PhD, Professor and Director of Health Promotion at the LSU Health Sciences Center New Orleans School of Public Health, showing early signs of diabetes in healthy children as young as seven years old will be presented at the American Diabetes Association 2009 Annual Scientific Session Meeting in New Orleans.
Pharmaceutical promotional items influence medical studentsExposure to small promotional items from pharmaceutical companies, such as clipboards and notepads, appears to influence medical students' unconscious attitudes toward the marketed product, according to a report in the May 11 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Job promotion bad for mental healthPromotion on average produces 10% more mental strain and gives up to 20% less time to visit the doctors, revealed by researchers in UK.
Uncertainty more stressful than negative feedbackWe are faced with uncertainty every day. Will our investments pay off? Will we get the promotions we are hoping for? When faced with the unknown, most people experience some degree of anxiety and discomfort.
Worksite-based weight loss programs good for obeseWorksite-based weight loss programs can result in modest short-term improvements in body weight, revealed by researchers in a study. The purpose of the study was to update a review on the effectiveness of worksite-based weight-loss programs.
Eli Lilly denied NYT report of schizophrenia drug ZyprexaEli Lilly and Company (NYSE: LLY) called the assertions in a New York Times online article 'flat out wrong.' A report in The New York Times that said a senior executive had encouraged the promotion of its schizophrenia drug Zyprexa for a use not approved by federal regulators.
Guidelines for information on unapproved uses of medical productsThe U.S. Food and Drug Administration (FDA) today issued draft guidance on "Good Reprint Practices" for industry use in the distribution of medical or scientific journal articles and reference publications that involve unapproved uses of FDA-approved drugs and medical devices.
7 Promotion articles listed above.
Mission
Health Newstrack is dedicated to serve recent and updated health & medical research, events/news, views/reviews to its subscribers and free access to general public, health & medical professionals, and other health seekers worldwide online with a user-friendly system.